Post-Genomic Cardiology
Autor José Marín-Garcíaen Limba Engleză Hardback – 17 iul 2014
This book, written by respected cardiologist José Marín-García, features discussion on the Hap-Map: the largest international effort to date aiming to define the differences between our individual genomes. This unique reference further reviews and investigates genome sequences from our evolutionary relatives that could help us decipher the signals of genes, and offers a comprehensive and critical evaluation of regulatory elements from the complicated network of the background DNA.
- Offers updated discussion of cutting-edge molecular techniques including new genomic sequencing / NGS / Hap-Map / bioinformatics / systems biology approaches
- Analyzes mitochondria dynamics and their role in cardiac dysfunction, up-to-date analysis of cardio-protection, and cardio-metabolic syndrome
- Presents recent translational studies, gene therapy, transplantation of stem cells, and pharmacological treatments in CVDs
Preț: 1153.28 lei
Preț vechi: 1427.25 lei
-19% Nou
Puncte Express: 1730
Preț estimativ în valută:
220.72€ • 232.85$ • 183.94£
220.72€ • 232.85$ • 183.94£
Carte tipărită la comandă
Livrare economică 26 decembrie 24 - 09 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780124045996
ISBN-10: 0124045995
Pagini: 944
Ilustrații: Illustrated
Dimensiuni: 216 x 276 x 53 mm
Ediția:Revised
Editura: ELSEVIER SCIENCE
ISBN-10: 0124045995
Pagini: 944
Ilustrații: Illustrated
Dimensiuni: 216 x 276 x 53 mm
Ediția:Revised
Editura: ELSEVIER SCIENCE
Public țintă
Cardiologists, Internists, Pathophysiologists, Pediatricians, Gerontologists, Basic Researchers, Medical and Graduate StudentsCuprins
Section I: Post-Genomic Cardiology 1. Introduction to the Molecular Biology of the Cell2. Methodologies in the Era of Cardiovascular “Omics 3. Post-Genomics Cardiovascular Signaling Pathways
Section II: Pediatric Cardiology in the Post-Genomic Era 4. Molecular Determinants of Cardiac Development 5. Molecular Determinants of Congenital Heart Disease
Section III: Post-Genomic Assessment of Coronary Artery Disease, Angiogenesis, and Hypertension 6. Molecular Determinants of Atherosclerosis7. Molecular Genetics of Coronary Artery Disease and Myocardial Infarction 8. Cellular and Molecular Aspects of Cardioprotection 9. Molecular Determinants of Cardiac Neovascularization 10. Post-Genomics Appraisal of Systemic and Pulmonary Hypertension
Section IV: Post-Genomic Analysis of the Myocardium 11. Post-Genomic Appraisal of Myocarditis 12. Cardiomyopathies: A Comparative Analysis of Phenotypes and Genotypes
Section V: Heart Failure, Cell Death, and Mitochondria Dynamics 13. Gene Profiling, Energy Metabolism, and Remodeling of the Failing Heart14. Oxidative Stress and Cell Death in Cardiovascular Disease: A Post-Genomic Appraisal 15. The Emerging Role of Mitochondrial Dynamics in Cardiovascular Disease
Section VI: Molecular and Genetic Analysis of Metabolic Disorders 16. Post-Genomic Analysis of Fatty Acid and Glucose Metabolism in Cardiovascular Disease
Section VII: Molecular Genetics of Dysrhythmias 17. Post-Genomic Analysis of Dysrhythmias and Sudden Death
Section VIII: Genes, Gender, and Epigenetics 18. Gender and Cardiovascular Disease in the Post-Genomic Era
Section IX: Aging and the Cardiovascular System 19. The Aging Heart: A Post-Genomic Appraisal 20. Targeted Strategies to Fight Cardiac Aging21. Aging and the Cardiovascular System: The Road Ahead
Section X: Genetics, Epigenetics, and New Approaches to Treatment 22. Epigenetics and Cardiovascular Disease23. Gene- and Cell-Based Therapy for Cardiovascular Disease
Section XI: Looking to the Future24. The Path to Personalized Cardiovascular Medicine
Section II: Pediatric Cardiology in the Post-Genomic Era 4. Molecular Determinants of Cardiac Development 5. Molecular Determinants of Congenital Heart Disease
Section III: Post-Genomic Assessment of Coronary Artery Disease, Angiogenesis, and Hypertension 6. Molecular Determinants of Atherosclerosis7. Molecular Genetics of Coronary Artery Disease and Myocardial Infarction 8. Cellular and Molecular Aspects of Cardioprotection 9. Molecular Determinants of Cardiac Neovascularization 10. Post-Genomics Appraisal of Systemic and Pulmonary Hypertension
Section IV: Post-Genomic Analysis of the Myocardium 11. Post-Genomic Appraisal of Myocarditis 12. Cardiomyopathies: A Comparative Analysis of Phenotypes and Genotypes
Section V: Heart Failure, Cell Death, and Mitochondria Dynamics 13. Gene Profiling, Energy Metabolism, and Remodeling of the Failing Heart14. Oxidative Stress and Cell Death in Cardiovascular Disease: A Post-Genomic Appraisal 15. The Emerging Role of Mitochondrial Dynamics in Cardiovascular Disease
Section VI: Molecular and Genetic Analysis of Metabolic Disorders 16. Post-Genomic Analysis of Fatty Acid and Glucose Metabolism in Cardiovascular Disease
Section VII: Molecular Genetics of Dysrhythmias 17. Post-Genomic Analysis of Dysrhythmias and Sudden Death
Section VIII: Genes, Gender, and Epigenetics 18. Gender and Cardiovascular Disease in the Post-Genomic Era
Section IX: Aging and the Cardiovascular System 19. The Aging Heart: A Post-Genomic Appraisal 20. Targeted Strategies to Fight Cardiac Aging21. Aging and the Cardiovascular System: The Road Ahead
Section X: Genetics, Epigenetics, and New Approaches to Treatment 22. Epigenetics and Cardiovascular Disease23. Gene- and Cell-Based Therapy for Cardiovascular Disease
Section XI: Looking to the Future24. The Path to Personalized Cardiovascular Medicine
Recenzii
"This Second edition of Post-Genomic Cardiology (PCG) deals with what promises to be the cardiology of the future. As the role of genetic screening in cardiology is strengthened, and as research on the multiple signaling pathways involved in cardiac organogenesis and pathology progresses, this 2nd edition of PCG further attempts to integrate known facts with what is still developing and with what is slowly becoming known. New areas of interest to cardiologists and researchers include systems biology, the constructive cycle of computational model building, and experimental verification. These are capable of providing the input necessary for exciting new discoveries, including the management of diseases in a “personalized” way. The book is fascinating because it introduces a field that no one with a minimum amount of scientific interest will be able to avoid in the very near future. Extensively referenced, and thoroughly researched, this book presents well-written and organized chapters, each with a summary of the important points discussed, followed by exhaustive bibliographies. A detailed glossary clearly defines the many acronyms used throughout the book. Unquestionably, this volume will be of great interest and use to clinical and research cardiologists, pharmacologists and genetics investigators; and to students of basic sciences. Dr. Marin-Garcia - author and editor of this 2nd edition of PGC has done an outstanding job of completing this challenging task." --Dr. Daniel Shindler
"This is a great book." --Dr. A. Bayes de Luna
"This is a great book." --Dr. A. Bayes de Luna